APACT: A phase III trial of nab-paclitaxel (nab-P) plus gemcitabine (Gem) versus Gem alone as adjuvant therapy for patients with resected pancreatic cancer (PC) Meeting Abstract
| Authors: | Tempero, M.; Cardin, D.; Biankin, A.; Goldstein, D.; Moore, M.; O'reilly, E.; Philip, P.; Riess, H.; Macarulla, T.; Yung, L.; Wei, X. Y.; Lu, B. |
| Abstract Title: | APACT: A phase III trial of nab-paclitaxel (nab-P) plus gemcitabine (Gem) versus Gem alone as adjuvant therapy for patients with resected pancreatic cancer (PC) |
| Meeting Title: | 79th Annual Scientific Meeting of the American College of Gastroenterology |
| Journal Title: | American Journal of Gastroenterology |
| Volume: | 109 |
| Issue: | Suppl.2 |
| Meeting Dates: | 2014 Oct 17-22 |
| Meeting Location: | Philadelphia, PA |
| ISSN: | 0002-9270 |
| Publisher: | Wolters Kluwer Health |
| Date Published: | 2014-10-01 |
| Start Page: | S72 |
| Language: | English |
| ACCESSION: | WOS:000344383100233 |
| PROVIDER: | wos |
| DOI: | 10.1038/ajg.2014.275 |
| Notes: | Meeting Abstract: 232 -- 79th Annual Scientific Meeting of the American-College-of-Gastroenterology -- OCT 17-22, 2014 -- Philadelphia, PA -- Source: Wos |
